LiveSBI Plans Separate Digital Bank, to Revamp App to ‘Only Yono’
State Bank of India (SBI) is planning a separate digital entity. It will revamp its current mobile application, rechristening it ‘Only Yono’, as part of...
Category : BUSINESS
Muthoot Microfin to Offer Healthcare in Rural India Via E-clinics
Muthoot Microfin has collaborated with M-SWASTH to set up e-clinics at its branches to offer accessible and affordable healthcare facilities in rural India. The MFI...
Zydus to Acquire US-based BridgeBio Pharma
Zydus Lifesciences said its subsidiary had acquired US-based BridgeBio Pharma. Sentynl Therapeutics, a subsidiary of Zydus Lifesciences and BridgeBio Pharma, have done an asset purchase...
IndiGo Gaines Upto 8% as Govt Lifts Ban on Overseas Flights
InterGlobe Aviation is the parent company of the low-cost airline IndiGo. SpiceJet gained up to 8 per cent on the BSE in Wednesday’s intra-day trade...
SEBI Raises Investment Limit Via UPI to Rs 5 Lakh for Retail Investors
On Tuesday, SEBI has increased the investment limit for payments through the UPI mechanism for retail investors buying debt securities in public issues to Rs...
Vikram Limaye Opts Out of 2nd Term as NSE CEO & MD
Vikram Limaye has decided not to seek reappointment as managing director and chief executive officer (MD & CEO) of the National Stock Exchange (NSE). This...
Morgan Stanley: Russia is Set for Venezuela-Style Debt Payment Default
The odds of Russia making its foreign debt payments are diminishing as bond prices fall, recession in the nation looms, and various payment restrictions pile...
PowerGrid Corporation Surges 5%, Hits Record High
On Tuesday, PowerGrid Corporation Ltd’s shares hit a record high of Rs 223.35 on rallied 5 per cent on the BSE intra-day trade amid heavy...
Aleor Dermaceuticals Gets FDA Nod For Anti-Fungal Drug
Alembic Pharmaceuticals announced that its joint venture, Aleor Dermaceuticals, has got the final nod from the US health regulator Food & Drug Administration (FDA) for...
Natco Pharma Gains 9%, Launches Generic Version of Revlimid in US
Shares of Natco Pharma rallied 9 per cent to Rs 920 on the BSE in Tuesday’s intra-day trade after the company launched its first generic...